The outbreak of swine flu is highlighting the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease, a new report says.

Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The makers of certain tests will benefit both in terms of sales and more broadly in recognition that their products play a vital role in making the public health community significantly better prepared for this possible pandemic than 1968 or before....

This Life Science Analytics’ Pipeline Report provides you with real detail on a company’s pipeline. It contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent news on the company including key milestones....